PROTAC FAK Degrader 1 is a small-molecule proteolysis-targeting chimera (PROTAC) designed to selectively induce degradation of focal adhesion kinase (FAK). Also known as Compound PROTAC-3, it is intended for research involving targeted protein degradation, FAK signaling, cancer biology, and drug discovery. The compound has demonstrated effective FAK degradation in experimental models and can be used for studies investigating tumor cell migration, invasion, and FAK-associated signaling pathways.
Product Specifications: Chemical name: (2S,4R)-1-((S)-3,3-dimethyl-2-(3-(2-(4-((4-((3-(N-methylmethylsulfonamido)benzyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)phenoxy)ethoxy)propanamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide; CAS No. 2301916-69-6; molecular formula C₄₇H₅₆F₃N₉O₈S₂; molecular weight 996.13 g/mol; purity ≥98%. The compound is soluble in DMSO. Store at −20°C under nitrogen. Prepared solutions can be stored at −80°C for up to 6 months or −20°C for up to 1 month under nitrogen.
Precautions: This product is intended for research use only (RUO) . Handle in accordance with appropriate laboratory safety procedures. Minimize exposure to moisture and air during storage, and avoid unnecessary repeated freeze–thaw cycles of prepared solutions. Experimental conditions should be optimized according to the specific research application.
关键字： PROTAC;FAK Degrader;Focal Adhesion Kinas;Anticancer Research;
杭州埃米尔生物技术有限公司位于浙江省杭州市钱塘区下沙街道安和药谷，立足杭州生物医药产业集聚区位优势，专注深耕ADC/XDC 生物偶联技术研发服务、医药小分子中间体定制合成两大核心业务，是聚焦抗体偶联药物上下游研发配套的专业化生物技术初创企业，面向药企、CRO 公司、高校科研院所提供从工艺开发、样品合成到质控分析的一站式技术外包解决方案。